A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

BACKGROUND: The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) was first described in 2012 and attracted a great international attention due to multiple healthcare associated outbreaks. The disease carries a high case fatality rate of 34.5%, and there is no internationally or nationally rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Momattin, Hisham, Al-Ali, Anfal Y., Al-Tawfiq, Jaffar A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110863/
https://www.ncbi.nlm.nih.gov/pubmed/31252170
http://dx.doi.org/10.1016/j.tmaid.2019.06.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110863/
https://www.ncbi.nlm.nih.gov/pubmed/31252170
http://dx.doi.org/10.1016/j.tmaid.2019.06.012

Ejemplares similares